JeanMarieTersakMD
Pediatric Hematology & Oncology • De Lancey, PAProfessor, Pediatrics, University of Pittsburgh School of Medicine
Dr. Tersak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4910 Penn Ave
De Lancey, PA 15733- Is this information wrong?
Education & Training
UPMC Medical EducationFellowship, Pediatric Hematology/Oncology, 1996 - 1999- UPMC Children's Hospital of PittsburghResidency, Pediatrics, 1993 - 1996
University of Pittsburgh School of MedicineClass of 1993
Certifications & Licensure
PA State Medical License 1994 - 2024- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
- Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors Start of enrollment: 2004 Feb 01
Completed
Phase 1
- Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma Start of enrollment: 2005 Jul 01
Terminated
Phase 2
- Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma Start of enrollment: 2008 Feb 04
Active, not recruiting
Phase 3
- Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2009 Feb 27
Recruiting
- Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Start of enrollment: 2004 Feb 16
Completed
- Childhood Cancer Survivor Study Start of enrollment: 1995 Jan 05
Recruiting
Roles: Contact, Principal Investigator
- Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Start of enrollment: 2010 Nov 22
Completed
Phase 2
- Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma Start of enrollment: 2011 Sep 01
Completed
Phase 1
- Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2013 Feb 12
Completed
Phase 2
- Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin Lymphoma Start of enrollment: 2013 Jan 31
Completed
Phase 1, Phase 2
- Stress Management Intervention for Mothers of Children With Cancer Start of enrollment: 2010 Sep 01
Completed
Not Applicable
- Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma Start of enrollment: 2014 Aug 01
Completed
Phase 2
- Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies Start of enrollment: 2014 May 16
Completed
Phase 1, Phase 2
- VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors Start of enrollment: 2014 Sep 01
Completed
Phase 1
- Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Start of enrollment: 2014 Jul 11
Active, not recruiting
Phase 2, Phase 3
- A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors Start of enrollment: 2015 Dec 11
Completed
Phase 1
- Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma Start of enrollment: 2019 Jul 08
Active, not recruiting
Phase 2
Roles: Principal Investigator
- Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial Start of enrollment: 2020 Oct 13
Active, not recruiting
Phase 2
Roles: Principal Investigator
- A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT Start of enrollment: 2020 Oct 19
Recruiting
Phase 2
Roles: Principal Investigator
- Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Start of enrollment: 2017 Aug 08
Recruiting
Phase 3
Roles: Principal Investigator
- A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects Start of enrollment: 2019 Oct 21
Recruiting
Phase 2
Roles: Principal Investigator, Contact
- Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma Start of enrollment: 2014 Aug 08
Active, not recruiting
Phase 3
Roles: Principal Investigator
- Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) Start of enrollment: 2018 Apr 17
Recruiting
Phase 2
Roles: Principal Investigator
- Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors Start of enrollment: 2017 Dec 06
Active, not recruiting
Roles: Principal Investigator
- Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer Start of enrollment: 2017 Nov 29
Recruiting
Phase 3
Roles: Principal Investigator
- Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) Start of enrollment: 2017 Jul 31
Recruiting
Phase 2
Roles: Principal Investigator
- Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors, the StepByStep Study Start of enrollment: 2020 Dec 07
Active, not recruiting
Phase 3
Roles: Principal Investigator
- A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations Start of enrollment: 2020 Jul 21
Active, not recruiting
Phase 3
Roles: Principal Investigator
- Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial) Start of enrollment: 2020 Jul 20
Active, not recruiting
Phase 2
Roles: Principal Investigator
- Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia Start of enrollment: 2019 Nov 08
Recruiting
Phase 2
Roles: Principal Investigator
- Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma Start of enrollment: 2019 Aug 29
Active, not recruiting
Phase 3
Roles: Principal Investigator
- Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma Start of enrollment: 2019 Aug 29
Active, not recruiting
Phase 3
Roles: Principal Investigator
- Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) Start of enrollment: 2017 Nov 28
Active, not recruiting
Phase 2
Roles: Principal Investigator
- Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL) Start of enrollment: 2018 May 14
Active, not recruiting
Phase 3
Roles: Principal Investigator
- Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors Start of enrollment: 2017 May 25
Recruiting
Phase 3
Roles: Principal Investigator
- Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial Start of enrollment: 2021 May 03
Active, not recruiting
Phase 2
Roles: Principal Investigator
- Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia Start of enrollment: 2018 Sep 09
Active, not recruiting
Phase 2
Roles: Principal Investigator
- Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial) Start of enrollment: 2017 Aug 23
Active, not recruiting
Phase 2
Roles: Principal Investigator
- A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery Start of enrollment: 2020 Oct 07
Active, not recruiting
Phase 2
Roles: Principal Investigator
- Project: Every Child for Younger Patients With Cancer Start of enrollment: 2015 Nov 03
Recruiting
Roles: Principal Investigator
- Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma Start of enrollment: 2022 Apr 01
Recruiting
Phase 3
Roles: Principal Investigator
- Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma Start of enrollment: 2022 Aug 04
Recruiting
Phase 3
Roles: Principal Investigator
- A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma Start of enrollment: 2021 Sep 14
Recruiting
Phase 3
Roles: Principal Investigator
- Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer Start of enrollment: 2022 Apr 08
Recruiting
Roles: Principal Investigator
- A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab Start of enrollment: 2023 May 11
Recruiting
Phase 3
Roles: Principal Investigator
- A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia Start of enrollment: 2023 Jun 12
Recruiting
Roles: Principal Investigator
- A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma Start of enrollment: 2023 Mar 03
Suspended
Phase 2, Phase 3
Roles: Principal Investigator
- A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma Start of enrollment: 2023 May 22
Recruiting
Roles: Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- Abnormal Global Longitudinal Strain During Anthracycline Treatment Predicts Future Cardiotoxicity in Children.Megan Gunsaulus, Tarek Alsaied, Jean M Tersak, Erika Friehling, Kirsten Rose-Felker> ;Pediatric Cardiology. 2023 Aug 22
- 1 citations"Pediatrician's Approach to Recognizing Neuroblastoma With Opsoclonus-Myoclonus-Ataxia Syndrome".Julia E Segal, A Kim Ritchey, Jean Tersak, Kavita Thakkar, Sanjay Lambore> ;Clinical Pediatrics. 2023 Sep 1
- 1 citationsA chronic eyelid lesion in a child: multi-disciplinary approach to diagnosis, treatment and management of a highly atypical histiocytic lesion.Archana Ramgopal, Julia Segal, Sabrina Mukhtar, Jenny Y. Yu, Jennifer Picarsic, Jean M. Tersak, Steven William Allen> ;Pediatric Hematology and Oncology. 2021 Aug 11
- 2 citationsMesenchymal chondrosarcoma of the chest wall in an adolescent patient: A case report and brief review of the literature.Marti Goldenberg, Archana Ramgopal, Cláudia M. Salgado, Miguel Reyes-Múgica, Marcus M. Malek, Jean M. Tersak> ;Cancer Reports. 2021 Jun 16
- 5 citationsEfficacy of a Stress Management Intervention for Mothers of Children with Cancer.Anna L. Marsland, Catherine P. Walsh, Jennifer L Cleary, Alina D Vaisleib, Chelsea H. Farrell, William C. Woods, Jean M. Tersak, Aidan G. C. Wright, Linda J. Ewing> ;Journal of Pediatric Psychology. 2020 Aug 1
- 6 citationsSedation practices in pediatric patients with acute lymphoblastic leukemiaBethany D. Nugent, Peter J. Davis, Robert B. Noll, Jean M. Tersak> ;Pediatric Blood & Cancer. 2020 Feb 1
- 13 citationsSolid organ transplantation after treatment for childhood cancer: a retrospective cohort analysis from the Childhood Cancer Survivor StudyAndrew C. Dietz, Kristy Seidel, Wendy M. Leisenring, Daniel A. Mulrooney, Jean M. Tersak, Richard D. Glick, Cathy A. Burnweit, Daniel M. Green, Lisa Diller, Susan A. S...> ;The Lancet. Oncology. 2019 Oct 1
- 7 citationsA germline BARD1 mutation in a patient with Ewing Sarcoma: Implications for familial testing and counselingRosemarie E. Venier, Lisa M. Maurer, Elena Kessler, Sarangarajan Ranganathan, Richard L. McGough, Kurt R. Weiss, Marcus M. Malek, Julia Meade, Jean M. Tersak, Kelly M....> ;Pediatric Blood & Cancer. 2019 Sep 1
- 10 citationsCognitive and Occupational Function in Survivors of Adolescent CancerBethany D. Nugent, Catherine M. Bender, Susan M. Sereika, Jean M. Tersak, Margaret Rosenzweig> ;Journal of Adolescent and Young Adult Oncology. 2017 Aug 7
- 22 citationsShared Care of Childhood Cancer Survivors: A Telemedicine Feasibility Study.Aimee G. Costello, Bethany D. Nugent, Noelle Calabro Conover, Amanda Moore, Kathleen Dempsey, Jean M. Tersak> ;Journal of Adolescent and Young Adult Oncology. 2017 Dec 1
- 1 citationsPartnering to optimize care of childhood cancer survivors.Bethany D. Nugent, Amanda Moore, Aimee Costello, Jean M. Tersak, Anna Marie White Lewarchik> ;The Journal of Family Practice. 2017 Apr 1
- 7 citationsJAK2+ Essential Thrombocythemia in a Young Girl With Budd-Chiari Syndrome: Diagnostic and Therapeutic Considerations When Adult Disease Strikes the Young.Julie C. Wigton, Jean M. Tersak> ;Journal of Pediatric Hematology/oncology. 2016 Jan 1
- 30 citationsA Pilot Trial of a Stress Management Intervention for Primary Caregivers of Children Newly Diagnosed With Cancer: Preliminary Evidence That Perceived Social Support Mo...Anna L. Marsland, Kristin A. Long, Chelsea Howe, Amanda L. Thompson, Jean M. Tersak, Linda J. Ewing> ;Journal of Pediatric Psychology. 2013 May 1
- 63 citationsHospitalization Rates Among Survivors of Childhood Cancer in the Childhood Cancer Survivor Study CohortBeth A. Kurt, Vikki G. Nolan, Kirsten K. Ness, Joseph P. Neglia, Jean M. Tersak, Melissa M. Hudson, Gregory T. Armstrong, Raymond J. Hutchinson, Wendy M. Leisenring, K...> ;Pediatric Blood & Cancer. 2012 Jul 15
- 115 citationsTwenty-five year follow-up of childhood Wilms tumor: A report from the Childhood Cancer Survivor Study†‡Amanda M. Termuhlen, Jean M. Tersak, Qi Liu, Yutaka Yasui, Marilyn Stovall, Rita E. Weathers, Melvin Deutsch, Charles A. Sklar, Kevin C. Oeffinger, Greg Armstrong, Les...> ;Pediatric Blood & Cancer. 2011 Dec 15
- 30 citationsRomantic relationships of emerging adult survivors of childhood cancer.Amanda L. Thompson, Anna L. Marsland, Michael P. Marshal, Jean M. Tersak> ;Psycho-Oncology. 2009 Jul 1
- 304 citationsSocial Outcomes in the Childhood Cancer Survivor Study CohortJames G. Gurney, Kevin R. Krull, Nina S. Kadan-Lottick, H. Stacy Nicholson, Paul C. Nathan, Brad Zebrack, Jean M. Tersak, Kirsten K. Ness> ;Journal of Clinical Oncology. 2009 May 10
- 98 citationsPediatric Phase I and Pharmacokinetic Study of Erlotinib Followed by the Combination of Erlotinib and Temozolomide: A Children's Oncology Group Phase I Consortium StudyRegina I. Jakacki, M. Hamilton, Richard J. Gilbertson, Susan M. Blaney, Jean M. Tersak, Mark Krailo, Ashish M. Ingle, Stephan D. Voss, Janet Dancey, Peter C. Adamson> ;Journal of Clinical Oncology. 2008 Oct 20
- 99 citationsTwenty years of follow-up among survivors of childhood and young adult acute myeloid leukemia: a report from the Childhood Cancer Survivor Study., , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Cancer. 2008 May 1
- 140 citationsHearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: a report from the Children's Oncology Group.James G. Gurney, Jean M. Tersak, Kirsten K. Ness, Wendy Landier, Katherine K. Matthay, Mary Lou Schmidt> ;Pediatrics. 2007 Nov 1
- 15 citationsRadiotherapy for symptomatic metastases to bone in children.Melvin Deutsch, Jean M. Tersak> ;American Journal of Clinical Oncology. 2004 Apr 1
- 420 citationsHigh Risk of Subsequent Neoplasms Continues With Extended Follow-Up of Childhood Hodgkin’s Disease: Report From the Late Effects Study GroupYutaka Yasui, Leslie L. Robison, Jillian M. Birch, Monica K. Bogue, Lisa Diller, Cyndi DeLaat, Franca Fossati-Bellani, Elaine R. Morgan, Odile Oberlin, G Reaman, Frede...> ;Journal of Clinical Oncology. 2003 Dec 1
- 123 citationsEducation, employment, insurance, and marital status among 694 survivors of pediatric lower extremity bone tumors: a report from the childhood cancer survivor study.Rajaram Nagarajan, M.P.H. Joseph P. Neglia M.D., Denis R. Clohisy, Yutaka Yasui, Mark Greenberg, Melissa M. Hudson, Michael A. Zevon, Jean M. Tersak, Arthur Ablin, Les...> ;Cancer. 2003 May 15
- 246 citationsUtilization of special education services and educational attainment among long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.Pauline Mitby, Leslie L. Robison, John Whitton, Michael A. Zevon, Iris C. Gibbs, Jean M. Tersak, Anna T. Meadows, Marilyn Stovall, Lonnie K. Zeltzer, Ann C. Mertens> ;Cancer. 2003 Feb 15
- 3 citationsNew cytogenetic variant, insertion (15;17)(q22;q12q21), in an adolescent with acute promyelocytic leukemia.Raj Rolston, Karen E. Weck, Jean M. Tersak, Maureen E. Sherer, Kathleen Cumbie, Sofia Shekhter-Levin> ;Cancer Genetics and Cytogenetics. 2002 Apr 1
- Join now to see all
Press Mentions
- Pitt Researchers Seek Participants in Study on Fracking and Childhood CancersSeptember 20th, 2022
- I Survived Childhood Cancer. Now What?September 9th, 2022
- I Survived Childhood Cancer. Now What? -News ForestAugust 20th, 2022
- Join now to see all
Hospital Affiliations
UPMC Children's Hospital of PittsburghPittsburgh, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
Similar Physicians & HCPs
Request an Appointment
Book an appointment with Dr. Stephan Grupp
Children's Hospital of Philadelphia
Request an Appointment
Book an appointment with Dr. Jacob Troutman
Lehigh Valley HospitalRequest an Appointment
Book an appointment with Dr. Jessica Foster
Children's Hospital of PhiladelphiaDoximity / States / Pennsylvania / De Lancey / Jean Tersak, MD
Dr. Jean Tersak, Dr. Jean Tersak, MD, Dr. J Tersak, Dr. Jean Marie Tersak